| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/03/2008 | US20080003236 Adenovirus fiber shaft composition and methods of use |
| 01/03/2008 | US20080003235 Vaccine Composition Comprising a Class II Cmh Lignd Coupled With an Antigen, Method for the Preparation and the Use Thereof |
| 01/03/2008 | US20080003228 Immunotherapy; combination with codeine phosphate, naproxen, diclofenac, indomethacin, or ibuprofen |
| 01/03/2008 | US20080003222 Inhibitors for L1 and Adam10 for the Treatment of Carcinomas |
| 01/03/2008 | US20080003220 Buffering agents for biopharmaceutical formulations |
| 01/03/2008 | US20080003217 Ilk inhibitors for the treatment of renal disease |
| 01/03/2008 | US20080003216 Administering an interleukin-18 binding protein (IL-18BP) for inhibiting melanoma cell liver and lung tissue metastasis; IL-18 (IFN gamma-inducing factor) |
| 01/03/2008 | US20080003214 Medicaments Comprising Carbonyl Compounds, And The Use Thereof |
| 01/03/2008 | US20080003213 Methods and compositions for the treatment of diseases or conditions associated with increased C-reactive protein, interleukin-6, or interferon-gamma levels |
| 01/03/2008 | US20080003212 ATP Diphosphohydrolase (CD39) Gene Therapy for Inflammatory or Thrombotic Conditions for Transplantation and Means Therefor |
| 01/03/2008 | US20080003211 Production and Purification of Recombinant Arylsulftase |
| 01/03/2008 | US20080003210 Non-human primate receptor tyrosine kinases |
| 01/03/2008 | US20080003209 Method for treatment of neurodegenerative diseases and the effects of aging |
| 01/03/2008 | US20080003202 Modified interferon-beta (IFN-beta) polypeptides |
| 01/03/2008 | US20080003201 Interleukin-12 as a veterinary vaccine adjuvant |
| 01/03/2008 | US20080003200 Tissue selective binding for prostate and/or bone cancer, or adipose tissue; apoptosis induction; diagnosis, prognosis; staging metastatic cancer |
| 01/03/2008 | US20080003199 IL-33 in the treatment and diagnosis of diseases and disorders |
| 01/03/2008 | US20080003198 Hernia treatment agents |
| 01/03/2008 | US20080003178 PIF tetrapeptides |
| 01/03/2008 | DE3890998B4 Neutrophilenaktivierungsfaktor, Verfahren zu seiner Herstellung und ihn enthaltende pharmazeutische Zusammensetzung Neutrophilenaktivierungsfaktor, process for its preparation and pharmaceutical composition containing it |
| 01/03/2008 | DE212006000025U1 Dermatologische Verwendung von Milchproteinen Dermatological use of milk proteins |
| 01/03/2008 | DE102006030164A1 Inhalative Pulver Inhalation powder |
| 01/03/2008 | CA2839595A1 Caspase-8 and inflammation, infection and wound healing |
| 01/03/2008 | CA2787343A1 Compositions comprising modified lcat and uses thereof |
| 01/03/2008 | CA2689241A1 Matrix and method for isolation of hepatic progenitor cells |
| 01/03/2008 | CA2656965A1 Medicaments |
| 01/03/2008 | CA2656604A1 Injectable formulation of antibiotic and solution for intravenous administration thereof |
| 01/03/2008 | CA2656463A1 Method of treatment of age-related macular degeneration |
| 01/03/2008 | CA2656221A1 Caspase-8 and inflammation, infection and wound healing |
| 01/03/2008 | CA2655849A1 Identification and use of gprc variants in the treatment and diagnosis of parkinson's disease |
| 01/03/2008 | CA2654652A1 Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 01/03/2008 | CA2654214A1 High frequency application of neurotoxic component of botulinum toxin |
| 01/03/2008 | CA2653756A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 01/03/2008 | CA2652957A1 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 01/02/2008 | EP1873259A1 RNA interference is mediated by 21 and 22nt small RNAs |
| 01/02/2008 | EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/02/2008 | EP1873244A2 Methods and compositions for inhibiting neoplastic cell growth |
| 01/02/2008 | EP1873164A1 High molecular weight poly-gamma-glutamic acid (> 2000 kDa) |
| 01/02/2008 | EP1872798A1 Intestinal absorptive anti-tumor agent |
| 01/02/2008 | EP1872797A2 Treatment of cardiovascular and related pathologies |
| 01/02/2008 | EP1872795A1 Therapeutic agent for irritable bowel syndrome |
| 01/02/2008 | EP1872790A1 New formulation for increasing bioavailability of neurturin |
| 01/02/2008 | EP1872668A1 Nutrient composition |
| 01/02/2008 | EP1872125A1 Isolation of inhibitor of ires-mediated translation |
| 01/02/2008 | EP1871880A2 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them |
| 01/02/2008 | EP1871811A2 Human glp-1 mimetibodies, compositions, methods and uses |
| 01/02/2008 | EP1871802A2 Recombinant e-selectin made in insect cells |
| 01/02/2008 | EP1871800A1 Methods for treating and preventing fibrosis by il-21 / il-21r antagonists |
| 01/02/2008 | EP1871798A2 Molecules and methods of using same for treating mcp-1/ccr2 associated diseases |
| 01/02/2008 | EP1871797A2 Toll-like receptor 14 (tlr14) and use thereof |
| 01/02/2008 | EP1871796A1 Vesiculins |
| 01/02/2008 | EP1871795A2 Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
| 01/02/2008 | EP1871794A1 Modified pyy(3-36) peptides and their effects on feeding behavior |
| 01/02/2008 | EP1871787A2 Polymyxin b analogs for lps detoxification |
| 01/02/2008 | EP1871786A1 Peptide vaccine for influenza virus |
| 01/02/2008 | EP1871408A2 Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor(tfpi) |
| 01/02/2008 | EP1871407A2 Compositions comprising wnt-3 peptide for modulating medial-lateral neuronal topographic maps |
| 01/02/2008 | EP1871406A1 Treatment of egfr dependent tumors by abin (a20-binding inhibitor of nf kappab) |
| 01/02/2008 | EP1871405A2 Use of rip in treating staphylococcus aureus infections |
| 01/02/2008 | EP1871404A1 Treatment of asthma |
| 01/02/2008 | EP1871403A2 Compositions and methods for the control, prevention, and treatment of obesity and eating disorders |
| 01/02/2008 | EP1871391A2 Endogenous retrovirus and proteins encoded by env as a target for cancer treatment |
| 01/02/2008 | EP1871348A2 Sustained release pharmaceutical compositions |
| 01/02/2008 | EP1871166A2 Cancer vaccines and therapeutic methods |
| 01/02/2008 | EP1691822A4 High-level expression of fusion polypeptides in plant seeds utilizing seed-storage proteins as fusion carriers |
| 01/02/2008 | EP1553962A4 Combination chemotherapy with chlorotoxin |
| 01/02/2008 | EP1548027B1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 01/02/2008 | EP1539214A4 Thrombin peptide derivatives |
| 01/02/2008 | EP1539207A4 Treatment of cell proliferative disorders with chlorotoxin |
| 01/02/2008 | EP1502116B1 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
| 01/02/2008 | EP1499346B1 Treatment of type 1 diabetes before and after expression of predisposition markers |
| 01/02/2008 | EP1472344B1 Bacteriophage lysin |
| 01/02/2008 | EP1465643B1 Methods and compositions for oxygen transport with high oxygen affinity |
| 01/02/2008 | EP1458410B1 Process for preparation of a mRNA tumour antigen library |
| 01/02/2008 | EP1448223B1 Thymosin augmentation of genetic immunization |
| 01/02/2008 | EP1435986B1 Igf-binding protein-derived peptide |
| 01/02/2008 | EP1432802B1 Pegylated and diglycosylated erythropoietin |
| 01/02/2008 | EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor |
| 01/02/2008 | EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 01/02/2008 | EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 01/02/2008 | EP1313760B1 Nucleotide sequences which code for the cita gene |
| 01/02/2008 | EP1278868B1 Mutated form of arginine deiminase |
| 01/02/2008 | EP1272161B1 Lipid-based drug delivery systems against parasitic infections |
| 01/02/2008 | EP1129177B1 Avipox vector coding an hiv antigen and gamma-interferon |
| 01/02/2008 | EP1098658A4 Engineered proteins for analyte sensing |
| 01/02/2008 | EP1073444B1 A food composition and method of using same |
| 01/02/2008 | EP0920514B1 Targeting adenovirus with use of constrained peptide motifs |
| 01/02/2008 | EP0863987B1 Vectors and methods for gene transfer to cells |
| 01/02/2008 | EP0830139B1 Modified myelin protein molecules |
| 01/02/2008 | EP0610335B1 Methods for designing recombitope peptides |
| 01/02/2008 | CN101098960A X-ray structure of human fpps and use for selecting fpps binding compounds |
| 01/02/2008 | CN101098889A Antibody induced cell membrane wounding |
| 01/02/2008 | CN101098888A TNF antagonists |
| 01/02/2008 | CN101098885A Fusion proteins comprising a non-cytotoxic protease, a targeting moiety, a protease cleavage site and a translocation domain |
| 01/02/2008 | CN101098882A Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 01/02/2008 | CN101098709A Use of a trpc channel for the treatment of a cardiovascular disease |
| 01/02/2008 | CN101098708A Treatment of an intestinal adenoma and/or adenocarcinoma by inhibition of Notch pathway activation |
| 01/02/2008 | CN101098707A Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 01/02/2008 | CN101098696A Improved dosing regimen of temozolomide for treating cancer based on the patient's mgmt level |
| 01/02/2008 | CN101098675A Stabilized calcium phosphate complexes |